Latest news with #regulatory
E&E News
3 days ago
- Politics
- E&E News
Former EPA lawyer lands at law firm
A former senior EPA enforcement adviser is joining the environmental practice at the law firm Crowell & Moring. Stacey Geis, former deputy assistant administrator at EPA, has joined the firm's environment, energy and natural resources and white collar and regulatory enforcement groups as senior counsel in the San Francisco office. Geis recently served at EPA headquarters as a senior adviser, then as a deputy assistant administrator. The firm says that during her tenure, Geis helped lead the 2,800-person enforcement and compliance assurance office, addressing climate change, PFAS (also known as 'forever chemicals'), and the revitalization of EPA's enforcement and compliance programs. Advertisement Geis also implemented two recent Supreme Court decisions: Sackett v. EPA, which limited the definition of wetlands under the Clean Water Act, and SEC v. Jarkesy, which limited the scope of federal administrative proceedings.
Finextra
5 days ago
- Business
- Finextra
Fenergo launches FinCrime operating system with agentic AI layer
Fenergo has today launched its FinCrime Operating System (OS), an evolution of its existing solutions to become the single unifying platform across the Client Lifecycle. 0 It leverages trusted Agentic AI to empower financial institutions to overcome spiraling operational costs and rising compliance demands enhanced by geopolitical tension and regulatory flux. Fenergo FinCrime OS, powered by an Agentic AI layer, unifies all client lifecycle events -onboarding, KYC, screening, identity and verification (ID&V) and transaction monitoring - on a single platform. The initial six autonomous AI agents execute tasks quickly, accurately, and with full auditability. These agents enable firms to automate tasks, gain real-time insights, and maintain full control and governance. Fenergo's FinCrime OS enhances client experiences with a seamless, digital-first approach to onboarding and KYC reviews, and smooth transaction monitoring alert workflows, while reducing operational costs by automating tasks, saving up to 93%. The FinCrime OS' Command Center strengthens risk mitigation through AI-driven insights, enabling better policy operationalization and minimizing regulatory risks. Built in line with global AI acts and regulatory guidelines, Fenergo's Agentic AI ensures sound governance with transparent actions, fostering trust and control. Unprecedented periodic review efficiencies Fenergo's initial six AI agents streamline periodic KYC reviews by autonomously handling tasks like data reconciliation, document classification, and risk screening. This reduces manual effort and backlog, enabling proactive, intelligent workflows and allowing compliance teams to focus on high-risk exceptions. Reducing periodic review timeframes by up to *45%, FinCrime OS not only ensures regulatory adherence but also drives operational efficiency and improved client experiences.* *Estimation of time saved on a straight-through processed (STP) periodic review for a low-risk client. The Six AI Agents available today include: 1. Data Sourcing Agent - Sources data from one or more third-party data provider, compares against entity data and auto-completes tasks 2. Screening Agent - Runs screening checks against third-party integrations, auto-resolves hits and returns results to providers 3. Document Agent - Extracts, classifies and links documents using AI to automate document-management processes 4. Significance Agent - Performs a check against data changes to determine significance to define next action 5. Autocompletion Agent - Automates the completion of tasks based on pre-defined rules, policy and configured guardrails 6. Insights Agent - Fenergo's co-pilot, allowing users to interact with all operational, policy and entity data through natural language and harness real-time insights on process efficiency, operations and risk. Command Center bolsters governance and streamlines KYC reviews Built into the FinCrime OS, the Command Center is a role-based daily landing page. It delivers personalized, real-time dashboards and data analytics, allowing users to observe all agent activity and maintain complete governance and control over entity data in line with global AI regulations. The Command Center also interacts with Fenergo's co-pilot for delivering insights and task and journey progress tracking. Marc Murphy, CEO, Fenergo, commented: 'Across the financial services industry compliance has become increasingly complex, costly and unsustainable. Fenergo's vision is to drive unprecedented change by transforming compliance from a reactive cost-center into a strategic competitive advantage. By re-imagining client lifecycle management through the lens of financial crime operations with intelligence and automation at its core, Fenergo's FinCrime OS will ultimately empower financial institutions to handle more clients, with fewer errors while streamlining operations. Compliance as a strategic engine for growth is our north star and FinCrime OS is a leap forward in realizing that vision.' Keith Redmond, Chief Product Officer at Fenergo, said: 'Our mission is to evolve Fenergo's CLM solution into an active, intelligent solution that empowers users to focus on the most critical business tasks. This is where agentic AI will be a game changer, allowing for faster onboarding, fewer manual errors and lower compliance risks. We are thrilled to be leading innovation through our FinCrime OS.' *estimation of time saved on a straight-through processed (STP) periodic review for a low-risk client.
Zawya
23-05-2025
- Business
- Zawya
Foundations and Evolutions of Structured Trade Finance, Second Edition By Professor Benedict O. Oramah
Structured Trade Finance (STF) is a highly specialised area of trade finance that has evolved directly from practice. As it grows and becomes more complex in an increasingly risk-based regulatory environment, there is a need for more detailed guidance on this subject. Now in its second edition, Foundations and Evolutions of Structured Trade Finance will provide you with exactly this. Written by Dr Benedict O. Oramah, president of Afreximbank and a key figure in the evolution of STF, this book delves into the philosophical foundations and risks associated with trade finance. It offers step-by-step guidance on structuring deals, explores the scope of coverage beyond commodities, and examines real-life case studies to draw valuable lessons. The new edition has been revised and updated, featuring brand new sections on reserve-based lending, supply chain finance, and new technologies for implementing structured trade finance. Publication information Author: Dr Benedict O. Oramah Publication date: May 2025 Format: Softback Pages: 421 Price: £195 ISBN: 9781837230822 For more information about this title, visit: Distributed by APO Group on behalf of Afreximbank. Notes to editors: To obtain a review copy of Foundations and Evolutions of Structured Trade Finance, Second Edition, please contact: Sian O'Neill (Managing Director) Globe Law and Business Ltd Phone number: 020 3745 4771 Email address: sian@ Website: About Globe Law and Business: Globe Law and Business was established in 2005. From the very beginning, we set out to create legal books that are sufficiently high level to be of real use to the experienced professional, yet still accessible and easy to navigate. Most of our authors are drawn from Magic Circle and other top commercial firms, both in the United Kingdom and internationally. Our titles are carefully produced, with the utmost attention paid to editorial, design, and production processes. In 2021, we were pleased to announce the start of a new chapter for Globe Law and Business following the acquisition of law books under the imprint Ark Publishing. We are also very pleased to announce the launch of our online content platform, Globe Law Online. This allows for easy search and networked access across firms, with key collections including the Law Firm Management Collection. Details of all titles included can be found at
National Post
22-05-2025
- Business
- National Post
The Cannabist Company Announces Receipt of Court Approval of Previously Announced Plan of Arrangement
Article content CHELMSFORD, Mass. — The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) ('The Cannabist Company' or the 'Company'), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today provided an update in respect of the previously announced plan of arrangement under Section 192 of the Canada Business Corporations Act (the 'Arrangement') involving the Company, The Cannabist Company Holdings (Canada) Inc. and 16834434 Canada Inc. Article content Article content The Company is pleased to announce that it has obtained the final order from the Ontario Superior Court of Justice (Commercial List) approving the Arrangement. Article content Further details of the Arrangement are described in the Company's management information circular dated March 28, 2025 in connection with the Arrangement, which is available under the Company's profile on SEDAR+ at and EDGAR at Article content The closing date of the Arrangement is targeted for on or around May 29, 2025, subject to receipt of all regulatory approvals, and the record date for determining the shareholders entitled to receive new warrants pursuant to the Arrangement will be two (2) business days prior to the closing date. Article content No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The securities being offered have not been registered under the U.S. Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws. Article content The Cannabist Company, formerly known as Columbia Care, is one of the most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 12 U.S. jurisdictions. The Company operates 81 facilities including 64 dispensaries and 17 cultivation and manufacturing facilities, including those under development. Columbia Care, now The Cannabist Company, is one of the original multi-state providers of cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the Company launched Cannabist, its retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit Article content Certain information contained in this news release may be forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as 'target', 'expect', 'anticipate', 'believe', 'foresee', 'could', 'would', 'estimate', 'goal', 'outlook', 'intend', 'plan', 'seek', 'will', 'may', 'tracking', 'pacing' and 'should' and similar expressions or words suggesting future outcomes. This news release includes forward-looking information and statements pertaining to, among other things, the implementation of the Arrangement and receipt of regulatory approvals. Numerous risks and uncertainties could cause the actual events and results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to the Company may not receive the necessary approvals to complete the Arrangement. Forward-looking estimates and assumptions involve known and unknown risks and uncertainties that may cause actual results to differ materially. The Company also cautions readers that the forward-looking financial information contained in this news release are only provided to assist readers in understanding management's current expectations relating to future periods and, as such, are not appropriate for any other purpose. In addition, securityholders should review the risk factors discussed under 'Risk Factors' in the Company's Form 10-K for the year ended December 31, 2024, as amended, as filed with Canadian and U.S. securities regulatory authorities and described from time to time in subsequent documents filed with applicable securities regulatory authorities. Article content Article content Article content Article content Contacts Article content Article content Article content
Bloomberg
20-05-2025
- Health
- Bloomberg
Roche Needs More US Data on Key Cancer Drug, FDA Advisers Say
A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in more American patients before its use can be expanded. Independent experts voted eight-to-one that the results of a pivotal Roche trial, which enrolled just 9% of its total patients from the US, weren't applicable to the domestic population. They asked the Swiss company to gather more data. Roche said in a statement it would continue working with the FDA on a regulatory path forward.
